Distillate Capital Partners LLC Makes New $17.80 Million Investment in Colgate-Palmolive Company $CL

Distillate Capital Partners LLC purchased a new position in Colgate-Palmolive Company (NYSE:CL) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 222,643 shares of the company’s stock, valued at approximately $17,799,000.

A number of other institutional investors have also modified their holdings of CL. DoubleLine ETF Adviser LP acquired a new position in Colgate-Palmolive during the 3rd quarter valued at approximately $3,292,000. Elevation Point Wealth Partners LLC boosted its holdings in shares of Colgate-Palmolive by 24.6% during the third quarter. Elevation Point Wealth Partners LLC now owns 4,063 shares of the company’s stock valued at $325,000 after acquiring an additional 801 shares during the period. EagleClaw Capital Managment LLC grew its position in shares of Colgate-Palmolive by 4.0% during the third quarter. EagleClaw Capital Managment LLC now owns 37,170 shares of the company’s stock worth $2,971,000 after acquiring an additional 1,421 shares during the last quarter. Bollard Group LLC increased its holdings in shares of Colgate-Palmolive by 5.3% in the 3rd quarter. Bollard Group LLC now owns 44,284 shares of the company’s stock worth $3,540,000 after acquiring an additional 2,212 shares during the period. Finally, Ausdal Financial Partners Inc. acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter worth about $385,000. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CL. Barclays boosted their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 3rd. The Goldman Sachs Group reaffirmed a “buy” rating and set a $100.00 price target on shares of Colgate-Palmolive in a report on Friday, February 20th. Argus restated a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Royal Bank Of Canada raised Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a research note on Tuesday, December 9th. Finally, Wells Fargo & Company increased their price target on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Sunday, February 1st. Eleven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Stock Performance

CL opened at $88.85 on Monday. The business has a 50 day moving average price of $90.11 and a two-hundred day moving average price of $83.22. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The company has a market capitalization of $71.62 billion, a price-to-earnings ratio of 33.91, a price-to-earnings-growth ratio of 3.98 and a beta of 0.28. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 EPS. Research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.4%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 79.39%.

Insider Buying and Selling at Colgate-Palmolive

In related news, insider John Hazlin sold 20,989 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the sale, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. The trade was a 54.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Panagiotis Tsourapas sold 15,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at $1,018,691.15. The trade was a 59.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 184,683 shares of company stock valued at $17,486,693 over the last 90 days. Insiders own 0.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.